Global and Japan Neurodegenerative Disease Treatment Market Size, Status and Forecast 2021-2027

Global and Japan Neurodegenerative Disease Treatment Market Size, Status and Forecast 2021-2027

  • QYResearch
  • January 2022
  • Healthcare
  • 106 pages

Report Description

Global Neurodegenerative Disease Treatment Scope and Market Size
Neurodegenerative Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Neurodegenerative Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Neurotransmitter Agents
Neuroprotective Agents
Biologics
Others

Segment by Application
Multiple Sclerosis [MS]
Alzheimers Disease
Parkinson's Disease
Acute Migraine
Autism
Narcolepsy
Amyotrophic Lateral Sclerosis [ALS]
Attention Deficit Hyperactivity Disorder [ADHD]
Spinal Muscular Atrophy

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Allergan plc
Bayer AG
F. Hoffmann La-Roche Ltd.
GlaxoSmithKline plc
Johnson & Johnson
Merck KGaA
Novartis AG
Pfizer, Inc.
Sanofi
Teva Pharmaceutical Industries Ltd.

Have query on this report?

Make an Enquiry
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurodegenerative Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Neurotransmitter Agents
List of Tables
Table 1. Global Neurodegenerative Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Neurotransmitter Agents
Table 3. Key Players of Neuroprotective Agents
Table 4. Key Players of Biologics
Table 5. Key Players of Others

Success Stories

Our Clients